Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery

NCT05385952 is registered in ClinicalTrials.gov with GATT Technologies BV as lead sponsor.

NCT NCT05385952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05385952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Clinical Investigation Evaluating the Safety and Efficacy of GATT-Patch Versus TachoSil for Hemostasis During Open Liver Surgery
Lead sponsor
GATT Technologies BV
Phase
Not applicable
Overall status
Completed
Start date
August 4, 2022
Completion date
May 10, 2024
Enrollment
132 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhage, surgical, intraoperative bleeding, liver diseases